Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The UK's Medical Research Council (MRC) has confirmed renewal of funding for Dementias Platform UK (DPUK), in partnership with industry and the third sector.

DPUK logo and people working

The renewal means DPUK will receive a further £7.5m from the MRC, with up to £8.5m from partners, in support of its aims. DPUK’s mission is to accelerate progress in dementia research by identifying the early signs of disease and supporting the translation of scientific discoveries into potential new treatments and preventive strategies.

Professor John Gallacher, Director of DPUK , said,

 

‘We are delighted to be able to confirm our renewed MRC funding, which means that many more scientists will have access to the technology, support and research resources needed to transform our understanding of dementia.

 

To read the full story.

For more information about the Dementias Platform UK.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Oxford has Largest Volume of World-Leading Research - REF 2021

Results of the Research Excellence Framework (REF) 2021 for UK universities indicate that Oxford has the largest volume of world-leading research*.

Cathy Creswell Elected Fellow of Academy of Medical Sciences

Cathy Creswell, Professor of Developmental Clinical Psychology, Departments of Psychiatry and Experimental Psychology, University of Oxford, has been elected a Fellow of the Academy of Medical Sciences.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

Anxiety Disorders Among Children, Assessment and Working with Families

Anxiety disorders are the most common mental health disorders among children, yet there is limited guidance on the process of assessing child anxiety disorders and sharing diagnostic outcomes with families.

Landmark New Clinical Trial Shows Benefits of Automated Virtual Reality (VR) Treatment for Severe Psychological Problems

The gameChange automated VR program is designed to treat agoraphobia in patients with psychosis. In the largest ever clinical trial of virtual reality for mental health, gameChange especially helped people whose anxiety had previously left them virtually housebound.

UK-Japanese Collaboration Researches Mental Health Challenges Faced by Young People and their Families

Dr Simona Skripkauskaite, Departments of Psychiatry and Experimental Psychology, University of Oxford, is the UK lead for one of the ten collaborative research projects jointly awarded by the Economic and Social Research Council (ESRC), the Arts and Humanities Research Council (AHRC) and the Japan Society for the Promotion of Science (JSPS), to address the challenges presented by the global pandemic.